A real world study of efficacy and safety with apatinib therapy in advanced neuroendocrine carcinoma patients.
2018
e14567Background: There is no standard therapeutic method for advanced neuroendocrine carcinoma patients after second line systemic therapy. It’s need novel effective therapies for these patients. ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI